Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Picornaviridae Infections | 7 | 2016 | 49 | 1.380 |
Why?
|
| Common Cold | 5 | 2016 | 25 | 1.130 |
Why?
|
| Rhinovirus | 6 | 2016 | 67 | 1.120 |
Why?
|
| Respiratory Tract Infections | 5 | 2016 | 298 | 0.900 |
Why?
|
| Coronavirus | 3 | 2016 | 27 | 0.820 |
Why?
|
| Coronavirus Infections | 3 | 2016 | 339 | 0.770 |
Why?
|
| Virus Diseases | 3 | 2005 | 285 | 0.370 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2010 | 650 | 0.260 |
Why?
|
| Respiratory Tract Diseases | 1 | 2003 | 83 | 0.180 |
Why?
|
| Immunocompromised Host | 3 | 2011 | 315 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 1 | 2002 | 223 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2005 | 400 | 0.150 |
Why?
|
| Acute Disease | 3 | 2007 | 1153 | 0.130 |
Why?
|
| Influenza, Human | 2 | 2005 | 712 | 0.120 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2016 | 22 | 0.120 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2016 | 39 | 0.120 |
Why?
|
| Antiviral Agents | 3 | 2007 | 807 | 0.110 |
Why?
|
| Otitis Media | 2 | 2007 | 88 | 0.110 |
Why?
|
| Sinusitis | 2 | 2007 | 118 | 0.100 |
Why?
|
| Cystic Fibrosis | 2 | 2007 | 268 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2010 | 110 | 0.080 |
Why?
|
| Viral Proteins | 1 | 2010 | 337 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1447 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1205 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 500 | 0.060 |
Why?
|
| Viridans Streptococci | 1 | 2006 | 7 | 0.060 |
Why?
|
| Asthma | 2 | 2007 | 922 | 0.060 |
Why?
|
| Penicillin Resistance | 1 | 2006 | 81 | 0.060 |
Why?
|
| Ceftriaxone | 1 | 2006 | 69 | 0.060 |
Why?
|
| Humans | 12 | 2016 | 131163 | 0.060 |
Why?
|
| Endocarditis, Bacterial | 1 | 2006 | 128 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 132 | 0.050 |
Why?
|
| Teaching | 1 | 2005 | 196 | 0.050 |
Why?
|
| Rhinitis | 1 | 2003 | 43 | 0.050 |
Why?
|
| Internet | 1 | 2005 | 420 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2002 | 156 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2002 | 259 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 218 | 0.040 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2002 | 256 | 0.040 |
Why?
|
| Seasons | 1 | 2002 | 335 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 262 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2002 | 324 | 0.040 |
Why?
|
| Recurrence | 1 | 2003 | 1489 | 0.040 |
Why?
|
| Risk Factors | 2 | 2002 | 11074 | 0.030 |
Why?
|
| Hospitalization | 1 | 2004 | 1950 | 0.030 |
Why?
|
| Age Factors | 1 | 2002 | 2825 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2596 | 0.030 |
Why?
|
| Aged | 3 | 2010 | 21025 | 0.020 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2010 | 34 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 144 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 152 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2010 | 158 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2010 | 188 | 0.020 |
Why?
|
| Adult | 3 | 2010 | 31282 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 633 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 544 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2010 | 439 | 0.020 |
Why?
|
| Pneumonia | 1 | 2010 | 341 | 0.020 |
Why?
|
| United States | 1 | 2002 | 12072 | 0.010 |
Why?
|
| Middle Aged | 4 | 2010 | 28601 | 0.010 |
Why?
|
| Family Practice | 1 | 2005 | 84 | 0.010 |
Why?
|
| Paramyxoviridae Infections | 1 | 2005 | 49 | 0.010 |
Why?
|
| Metapneumovirus | 1 | 2005 | 54 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2885 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2005 | 185 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 2006 | 254 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 202 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 413 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 69 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 5196 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4738 | 0.010 |
Why?
|
| Male | 4 | 2010 | 64957 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 822 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 1155 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 919 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 18301 | 0.010 |
Why?
|
| Female | 2 | 2010 | 70963 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12936 | 0.000 |
Why?
|
| Animals | 1 | 2010 | 33912 | 0.000 |
Why?
|